Previously, Ji et al. have described that ATO can function as an anti‐angiogenic agent in PCa by inhibition of TGF‐β/SMAD pathway, which is crucial in VEGF secretion.11 The gene discussed is VEGFA; the disease is posterior cortical atrophy.